EUVIMEDEUVIMED entdecken
Open Access

DESIGNER fraction concept unmasks minor bioactive constituents in red clover (Trifolium pratense L.)

Ryan Hitzman, Gonzalo R Malca-Garcia, Caitlin Howell, Hyun-Young Park, J Brent Friesen, Huali Dong, Tareisha Dunlap, James B McAlpine, Guenter Vollmer, Maarten C Bosland, Dejan Nikolić, David C Lankin und 4 weitere

Phytochemistry · 2023

DOI: 10.1016/j.phytochem.2023.113789 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Phytochemistry, 2023. Verfasst von Ryan Hitzman und 15 weiteren Autor:innen. Beteiligte Einrichtung: UIC Center for Botanical Dietary Supplements Research and Center for Natural Product Technologies, Pharmacognosy Institute, and Department of Pharmac…. Hauptthemen laut MEDLINE: Trifolium, Isoflavones, Breast Neoplasms. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 57 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIEHS NIH HHS, NCCIH NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

In botanical extracts, highly abundant constituents can mask or dilute the effects of other, and often, more relevant biologically active compounds. To facilitate the rational chemical and biological assessment of these natural products with wide usage in human health, we introduced the DESIGNER approach of Depleting and Enriching Selective Ingredients to Generate Normalized Extract Resources. The present study applied this concept to clinical Red Clover Extract (RCE) and combined phytochemical and biological methodology to help rationalize the utility of RCE supplements for symptom management in postmenopausal women. Previous work has demonstrated that RCE reduces estrogen detoxification pathways in breast cancer cells (MCF-7) and, thus, may serve to negatively affect estrogen metabolism-induced chemical carcinogenesis. Clinical RCE contains ca. 30% of biochanin A and formononetin, which potentially mask activities of less abundant compounds. These two isoflavonoids are aryl hydrocarbon receptor (AhR) agonists that activate P450 1A1, responsible for estrogen detoxification, and P450 1B1, producing genotoxic estrogen metabolites in female breast cells. Clinical RCE also contains the potent phytoestrogen, genistein, that downregulates P450 1A1, thereby reducing estrogen detoxification. To identify less abundant bioactive constituents, countercurrent separation (CCS) of a clinical RCE yielded selective lipophilic to hydrophilic metabolites in six enriched DESIGNER fractions (DFs 01-06). Unlike solid-phase chromatography, CCS prevented any potential loss of minor constituents or residual complexity (RC) and enabled the polarity-based enrichment of certain constituents. Systematic analysis of estrogen detoxification pathways (ERα-degradation, AhR activation, CYP1A1/CYP1B1 induction and activity) of the DFs uncovered masked bioactivity of minor/less abundant constituents including irilone. These data will allow the optimization of RCE with respect to estrogen detoxification properties. The DFs revealed distinct biological activities between less abundant bioactives. The present results can inspire future carefully designed extracts with phytochemical profiles that are optimized to increase in estrogen detoxification pathways and, thereby, promote resilience in women with high-risk for breast cancer. The DESIGNER approach helps to establish links between complex chemical makeup, botanical safety and possible efficacy parameters, yields candidate DFs for (pre)clinical studies, and reveals the contribution of minor phytoconstituents to the overall safety and bioactivity of botanicals, such as resilience promoting activities relevant to women's health.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

TrifoliumIsoflavonesBreast NeoplasmsFemaleHumansEstrogensPlant Extracts

Stichwörter der Autor:innen

AhR activationCountercurrent separationDESIGNER conceptEstrogen detoxification pathwaysIsoflavonesResidual complexityTrifolium pratense L.

Substanzen

IsoflavonesEstrogensPlant Extracts

Autor:innen und Institutionen

  • UIC Center for Botanical Dietary Supplements Research and Center for Natural Product Technologies, Pharmacognosy Institute, and Department of Pharmaceutical Sciences, College of Pharmacy, University of Illinois Chicago,…
  • Department of Pathology, College of Medicine, University of Illinois Chicago, 840 S. Wood Street, Chicago, IL, 60612, USA.

Förderung

  • NIEHS NIH HHS
  • NCCIH NIH HHS

Zitieren

APA

Hitzman, R., Malca-Garcia, G. R., Howell, C., Park, H. Y., Friesen, J. B., Dong, H., Dunlap, T., McAlpine, J. B., Vollmer, G., Bosland, M. C., Nikolić, D., Lankin, D. C., Chen, S. N., Bolton, J. L., Pauli, G. F., & Dietz, B. M. (2023). DESIGNER fraction concept unmasks minor bioactive constituents in red clover (Trifolium pratense L.). Phytochemistry. https://doi.org/10.1016/j.phytochem.2023.113789

Vancouver

Hitzman R, Malca-Garcia GR, Howell C, Park HY, Friesen JB, Dong H, et al. DESIGNER fraction concept unmasks minor bioactive constituents in red clover (Trifolium pratense L.). Phytochemistry. 2023. doi:10.1016/j.phytochem.2023.113789

BibTeX
@article{Hitzman2023,
  author = {Hitzman, Ryan and Malca-Garcia, Gonzalo R and Howell, Caitlin and Park, Hyun-Young and Friesen, J Brent and Dong, Huali and Dunlap, Tareisha and McAlpine, James B and Vollmer, Guenter and Bosland, Maarten C and Nikolić, Dejan and Lankin, David C and Chen, Shao-Nong and Bolton, Judy L and Pauli, Guido F and Dietz, Birgit M},
  title = {DESIGNER fraction concept unmasks minor bioactive constituents in red clover (Trifolium pratense L.)},
  journal = {Phytochemistry},
  year = {2023},
  doi = {10.1016/j.phytochem.2023.113789}
}
Kostenlos starten →